Printer-friendly version
BIOPAD™ is a primary dressing composed of 100% native equine type I collagen that can accelerate the closure of hard-to-heal wounds.
• Protects the wound bed from outer environment and infective agents
• Stimulates formation of new granulation tissue and deposition of new collagen fibers
• Ability to absorb exudate in the wound bed
• 100% pure collagen
• Native in structure and triple helix formation
BIOPAD™ is indicated for use on pressure injuries, surgical wounds, draining wounds, venous ulcers, diabetic ulcers, partial- and full-thickness wounds, and dehisced wounds.
Store at room temperature, 5-year shelf life.
Type I equine collagen
| Antimicrobial format available | |
| Compatible w/ topicals | |
| Conforms readily to wound | ● |
| Cuttable | ● |
| Flexible | ● |
| Gels on contact w/ exudate | ● |
| Limited shelf life | |
| Moldable | ● |
| Powder | |
| Rope | |
| Secondary dressing required | ● |
| Silicone-based adhesive | |
| Usable on infected wounds | ● |
| Variety of sizes |
| Educational Material Available | ● |
| Free Samples/Trials Available | ● |
| Published Clinical Article Available | ● |
Acute Wounds
Burns
Cavity Wounds
Chronic Wounds
Deep Wounds
Dehisced Wounds
Diabetic Foot
Infected Wounds
Non/Minimally Exudating Wounds
Palliative Wounds
Pressure Ulcers
Superficial Wounds
Surgical Wounds
Traumatic Wounds
Venous Ulcers
Prepare wound bed. Cut BIOPAD™ to fit wound. Hydrate if placed on dry wounds. Cover entire wound bed. Transforms into a gel that does not need to be removed. Apply secondary dressing. Check daily and change if needed.
Daily dressing change but can be left longer if needed.
Secure BIOPAD™ with a secondary dressing of choice.
Latex-friendly
Non-comedogenic
Non-cytotoxic
Non-irritating
L&R USA, Inc. (L&R) is part of a leading global medical device company, which has been delivering high-quality health care products for over 160 years. L&R USA, Inc. is dedicated to providing health care professionals product solutions in the treatment of wounds, edema, venous disease, and lymphedema to improve patient care and outcomes.